Source: Virtual Congress 2021 – Non-invasive respiratory support in COVID-19



Rating:

Share or cite this content

Citations should be made in the following way:
L. Tokhi (Värnamo, Sweden), M. Roglic (Värnamo, Sweden), J. Paluero (Värnamo, Sweden), M. Labor (Värnamo, Sweden). Timely start of HFNC treatment is beneficial for the outcome in COVID-19. 1082

Member's Comments

No comment yet.

Related content which might interest you: Pre-discharge assessment and outcomes of patients commenced on short-term oxygen therapy Source: International Congress 2018 – Integrated care and non-pharmacological management of COPD Year: 2018 MDR/XDR-TB treatment outcome Source: Annual Congress 2009 - Treatment of tuberculosis at times of emerging drug resistance Year: 2009 Evaluation of CPAP treatment at 3 months as a tool to predict long-term compliance Source: Eur Respir J 2005; 26: Suppl. 49, 724s Year: 2005 Impact of different positive airway pressure-therapy care models on longer-term therapy termination rates Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence Year: 2020 Long-term effectiveness of surgery treatment of TB patients Source: Virtual Congress 2020 – Tuberculosis and adverse events in different populations Year: 2020 Predictors of pressure time product at different levels of nCPAP in neonates: A method to optimise nCPAP therapy? Source: Annual Congress 2010 - Paediatric and neonatal intensive care Year: 2010 Feedback on inhaler use does not significantly improve inhaled corticosteroid adherence or clinical outcomes Source: Virtual Congress 2020 – Digital technologies in airway diseases Year: 2020 Does CPAP use reflect effective CPAP treatment? Source: Eur Respir J 2002; 20: Suppl. 38, 562s Year: 2002 An intervention to modify patients‘ beliefs about maintenance therapy and improve adherence to medication Source: Eur Respir J 2005; 26: Suppl. 49, 46s Year: 2005 Early treatment response may predict long-term mepolizumab benefit in severe asthma Source: International Congress 2019 – Treatment of asthma with monoclonal antibodies Year: 2019 Evaluating the efficacy of chronic therapy with tiotropium in COPD through discontinuation of treatment Source: Eur Respir J 2002; 20: Suppl. 38, 245s Year: 2002 The effect of resection surgery on long-term treatment outcomes of patients with MDR/XDR-TB Source: International Congress 2017 – Treatment of multi-drug-resistant tuberculosis (MDRTB): where are we now? Year: 2017 Effect of early application of non-invasive ventilation on extubation outcomes Source: Eur Respir J 2003; 22: Suppl. 45, 403s Year: 2003 Early detection of asthma exacerbations and the use of action points for treatment decisions in self-management plans Source: Annual Congress 2011 - Monitoring exacerbations of airway diseases Year: 2011 Impact of an educational intervention to improve adherence to treatment with continuous pressure airway positive Source: Annual Congress 2012 - Clinical predictors of OSA, adherence to CPAP and psychology Year: 2012 The effectiveness of urgent starting therapy of home pneumonia at the pre-hospital stage Source: Annual Congress 2009 - Pulmonary infections Year: 2009 Time to ban short-acting ß-agonists and use anti-inflammatory treatment as required to improve outcomes Source: Virtual Congress 2021 – Wheezing illnesses along the life span Year: 2021